RAD9A and neoplasm: According to the Cancer Genome Atlas/TCGA (https://cancergenome.nih.gov/), RAD9A is overexpressed in a wide variety of tumors including leukemia and solid tumors, supporting its oncogenic function but the relationship between tumor type, survival and RAD9A hypermethylation demands studying larger patients cohorts.